Presentation is loading. Please wait.

Presentation is loading. Please wait.

Pet Cancer Therapeutics Market share to surpass $300mn by 2024

Similar presentations


Presentation on theme: "Pet Cancer Therapeutics Market share to surpass $300mn by 2024"— Presentation transcript:

1 © 2016 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com Fuel Cell Market size worth $25.5bn by 2024 Pet Cancer Therapeutics Market forecast to reach $300mn by 2024: Global Market Insights Inc.

2 © 2016 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com  Growing pet adoption rate coupled with increasing disposable income of pet owners will drive pet cancer therapeutics market growth. Strong and robust drug pipeline for treatment of pet cancer will stimulate business growth over the forecast years.  High cost of pet cancer drugs along with rising instances of adverse drug events should hamper industry growth over the forecast years. Lack of awareness regarding pet diseases among the pet owners will impede industry expansion.  Chemotherapy has been the mainstream medication for pet cancers till recent times.  Dogs are more prone to develop cancer than cats and the healthy pipeline will drive segment growth over the forecast years. However, introduction of specialized cat cancer medicines will stimulate the cat cancer therapeutics market growth.  Pet healthcare companies are focusing on development of drugs for mast cell cancer and melanoma among other cancer types. Key Insights from Pet Cancer Therapeutics Market:

3 © 2016 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com  This trend will witness change as medicines to treat lymphoma and mammary cell cancer are in the pipeline. Innovative medicines for treatment of multiple cancer tumors is anticipated to accelerate business growth.  U.S. pet cancer therapeutics market holds the largest revenue share in 2016. Presence of large number of pet drug manufacturing companies, quick adoption of innovative pet care medicines and increasing disposable income of pet owners will boost industry growth.  Australia pet cancer therapeutics market held highest regional revenue share in 2016 owing to growing pet-keeping trend, availability of innovative pet care medicines and increasing disposable income of pet owners.  Some of the leading industry players include Zoetis, Merial, Aratana Therapeutics, AB Science, Vetivax, Oasmia Pharmaceutical, VetDC, Regeneus, CanFel Therapeutics, Karyopharms Verdinexor.  The most commonly adopted business strategies by industry participants includes new product launches, regional expansion and mergers and acquisition. Continued...

4 © 2016 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com U.S Pet cancer therapeutics market, by medicine type, 2013 - 2024 (USD Million)

5 © 2016 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com Browse Full Market Research Report On Pet Cancer Therapeutics Market @ http://bit.ly/2fxZquXhttp://bit.ly/2fxZquX Request for a Sample of this Research Report @ https://www.gminsights.com/request-sample/detail/2017 https://www.gminsights.com/request-sample/detail/2017 https://www.gminsights.com/request-sample/detail/49

6 © 2016 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com Stay In Touch Website: www.gminsights.comwww.gminsights.com Social Media:


Download ppt "Pet Cancer Therapeutics Market share to surpass $300mn by 2024"

Similar presentations


Ads by Google